Evidence map›Paper›PMID 30524729›Full record

ReviewMultidisciplinary respiratory medicine2018

From CPAP to tailored therapy for obstructive sleep Apnoea.

Kate Sutherland, Kristina Kairaitis, Brendon J Yee, Peter A Cistulli

Open access · goldAbstract readReview
In one paragraph

Review in Multidisciplinary respiratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Beyond hours per night: rethinking oral appliance adherence in OSA.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Sleep-Disordered Breathing and Cardiac Arrhythmias.Journal of clinical medicine · 2024
    Review
  11. Article
  12. Sleep Apnea and Heart Failure-Current State-of-The-Art.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Comorbidity clusters in patients with moderate-to-severe OSA.Sleep & breathing = Schlaf & Atmung · 2022
    Article
  17. Article
  18. Treatment usage patterns of oral appliances for obstructive sleep apnea over the first 60 days: a cluster analysis.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kate Sutherland1Charles Perkins Centre, The University of Sydney, Sydney, Australia.
Kristina Kairaitis1Charles Perkins Centre, The University of Sydney, Sydney, Australia.
Brendon J Yee2Faculty of Medicine & Health, The University of Sydney School of Medicine, Sydney, Australia.
Peter A Cistulli1Charles Perkins Centre, The University of Sydney, Sydney, Australia.ORCID 0000-0002-7920-4924
The University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive Sleep Apnoea (OSA) is a common sleep disorder that is associated with daytime symptoms and a range of comorbidity and mortality. Continuous Positive Airway Pressure (CPAP) therapy is highly efficacious at preventing OSA when in use and has long been the standard treatment for newly diagnosed patients. However, CPAP therapy has well recognised limitations in real world effectiveness due to issues with patient acceptance and suboptimal usage. There is a clear need to enhance OSA treatment strategies and options. Although there are a range of alternative treatments (e.g. weight loss, oral appliances, positional devices, surgery, and emerging therapies such as sedatives and oxygen), generally there are individual differences in efficacy and often OSA will not be completely eliminated. There is increasing recognition that OSA is a heterogeneous disorder in terms of risk factors, clinical presentation, pathophysiology and comorbidity. Better characterisation of OSA heterogeneity will enable tailored approaches to therapy to ensure treatment effectiveness. Tools to elucidate individual anatomical and pathophysiological phenotypes in clinical practice are receiving attention. Additionally, recognising patient preferences, treatment enhancement strategies and broader assessment of treatment effectiveness are part of tailoring therapy at the individual level. This review provides a narrative of current treatment approaches and limitations and the future potential for individual tailoring to enhance treatment effectiveness.

Indexed as

Continuous positive airway pressureObstructive sleep ApnoeaPersonalised medicinePhenotypingTreatment

Identifiers

PMID30524729
PMCPMC6276208
OpenAlexW2901961414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.